Suppr超能文献

6-脱氧红霉内酯B合酶1在模块2的β-酮酰基-酰基载体蛋白合酶结构域被一种二酮中间体特异性酰化。

6-deoxyerythronolide B synthase 1 is specifically acylated by a diketide intermediate at the beta-ketoacyl-acyl carrier protein synthase domain of module 2.

作者信息

Tsukamoto N, Chuck J A, Luo G, Kao C M, Khosla C, Cane D E

机构信息

Department of Chemistry, Brown University, Providence, Rhode Island 02912, USA.

出版信息

Biochemistry. 1996 Dec 3;35(48):15244-8. doi: 10.1021/bi961972f.

Abstract

We have used 6-deoxyerythronolide B synthase (DEBS) as a model system to investigate molecular recognition by a modular polyketide synthase (PKS). DEBS consists of three proteins (DEBS1, -2, and -3) that biosynthesize the polyketide skeleton of the antibiotic erythromycin from propionyl-CoA and methylmalonyl-CoA. Active sites within these multifunctional proteins are organized into biosynthetic "modules", each of which catalyzes a discrete round of polyketide chain elongation and adjusts the appropriate level of beta-ketoacylthioester reduction. Using DEBS1, we demonstrate that there is a substantial degree of molecular recognition in the processing of the natural diketide chain elongation intermediate. Exogenously added (2S,3R)-2-methyl-3-hydroxypentanoic acid N-acetylcysteamine thioester is exclusively recognized by its cognate beta-ketoacyl-acyl carrier protein synthase domain in module 2 (KS2). Labeled diketide specifically acylated DEBS1 in crude protein extracts and limited proteolysis localized the binding to module 2. The precise site of acylation in DEBS1 was established by the finding that a Cys2200 Ala mutant of DEBS1, lacking the KS2 active-site cysteine, did not undergo acylation by the diketide. Pretreatment of the wild-type protein with the beta-ketoacyl-ACP synthase inhibitor cerulenin also blocked acylation. These results indicate that in addition to the purely organizational consequences resulting from the order of active-site domains, the programming of polyketide biosynthesis by modular PKSs involves a substantial level of molecular recognition. This conclusion has important implications for the use of PKSs to rationally design novel polyketides.

摘要

我们使用6-脱氧红霉内酯B合酶(DEBS)作为模型系统,来研究模块化聚酮合酶(PKS)的分子识别。DEBS由三种蛋白质(DEBS1、DEBS2和DEBS3)组成,它们从丙酰辅酶A和甲基丙二酰辅酶A生物合成抗生素红霉素的聚酮骨架。这些多功能蛋白质中的活性位点被组织成生物合成“模块”,每个模块催化一轮离散的聚酮链延伸,并调节β-酮酰硫酯还原的适当水平。利用DEBS1,我们证明在天然二酮链延伸中间体的加工过程中存在相当程度的分子识别。外源添加的(2S,3R)-2-甲基-3-羟基戊酸N-乙酰半胱氨酸硫酯仅被其在模块2(KS2)中的同源β-酮酰-酰基载体蛋白合酶结构域识别。标记的二酮在粗蛋白提取物中特异性酰化DEBS1,有限蛋白酶解将结合定位到模块2。通过发现DEBS1的Cys2200 Ala突变体(缺乏KS2活性位点半胱氨酸)不被二酮酰化,确定了DEBS1中的精确酰化位点。用β-酮酰-ACP合酶抑制剂浅蓝菌素预处理野生型蛋白也阻断了酰化。这些结果表明,除了活性位点结构域顺序产生的纯粹组织后果外,模块化PKS对聚酮生物合成的编程还涉及相当程度的分子识别。这一结论对利用PKS合理设计新型聚酮具有重要意义。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验